IP Library Assignment 048329/0045
Patent Assignment
Reel/Frame 048329/0045

Security Interest

Recorded: 2019-02-13 Pages: 15
Assignors
EYEPOINT PHARMACEUTICALS, INC.
Executed: 2019-02-13
EYEPOINT PHARMACEUTICALS US, INC.
Executed: 2019-02-13
ICON BIOSCIENCE, INC.
Executed: 2019-02-13
Assignee
CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
1000 MAIN STREET, SUITE 2500, HOUSTON, TEXAS, 77002
Covered Properties (49)
Sustained Release Delivery Devices
Sustained Release Drug Delivery Devices
Patent: 5,902,598 →
Application: 08/919,221 →
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent: 6,217,895 →
Application: 09/273,548 →
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 6,375,972 →
Application: 09/558,207 →
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent: 6,548,078 →
Application: 09/735,636 →
Publication: US 2002/0127250
Implantable Refillable and Ported Controlled Release Drug Delivery Device
Patent: 6,852,106 →
Application: 10/013,946 →
Publication: US 2002/0138068
Device and Method for Treating Conditions of a Joint
Patent: 6,936,270 →
Application: 10/139,143 →
Publication: US 2003/0139811
Stent Coated with a Sustained-Release Drug Delivery and Method for Use Thereof
Patent: 7,279,175 →
Application: 10/245,840 →
Publication: US 2003/0108588
Injectable sustained release delivery devices
Patent: 8,871,241 →
Application: 10/714,549 →
Publication: US 2004/0176341
Bioerodible Sustained Release Drug Delivery Systems
Patent: 8,815,284 →
Application: 10/877,761 →
Publication: US 2005/0025834
Injector Apparatus and Method of Use
Patent: 7,998,108 →
Application: 11/900,907 →
Publication: US 2008/0071246
Method for Treating and/or Preventing Retinal Diseases with Sustained Release Corticosteroids
Patent: 8,252,307 →
Application: 12/684,341 →
Publication: US 2010/0168073
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 8,574,659 →
Application: 12/688,132 →
Publication: US 2010/0119694
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 8,574,613 →
Application: 12/689,956 →
Publication: US 2010/0119580
Ocular Trocar Assembly
Patent: 8,192,408 →
Application: 12/703,634 →
Publication: US 2010/0234817
Porous Silicon Drug-Eluting Particles
Patent: 9,023,896 →
Application: 12/773,127 →
Publication: US 2010/0278931
Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents
Patent: 9,333,173 →
Application: 13/286,788 →
Publication: US 2012/0177695
Injector Apparatus with Fixed Plunger and Method of Use
Patent: 8,790,293 →
Application: 13/763,587 →
Publication: US 2013/0267931
Polymer-Based, Sustained Release Drug Delivery System
Application: 13/937,844 →
Publication: US 2014/0037746
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 9,192,579 →
Application: 14/057,847 →
Publication: US 2014/0107594
Dose Guides for Injection Syringe
Application: 14/113,803 →
Publication: US 2014/0180245
Sustained Release Formulations for Delivery of Proteins to the Eye and Methods of Preparing Same
Patent: 9,814,773 →
Application: 14/124,631 →
Publication: US 2014/0140992
Sustained Release Formulations for the Treatment of Intraocular Pressure or Glaucoma
Patent: 9,283,231 →
Application: 14/168,139 →
Publication: US 2014/0213646
Drug Delivery Device Comprising Silicon-Based Carrier Particles
Application: 14/206,823 →
Publication: US 2014/0309610
Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents
Patent: 9,603,801 →
Application: 14/211,170 →
Publication: US 2014/0271886
Bioerodible Sustained Release Drug Delivery Systems
Application: 14/320,940 →
Publication: US 2014/0363482
In Situ Gelling Drug Delivery System
Patent: 9,566,336 →
Application: 14/444,338 →
Publication: US 2014/0336278
Porous Silicon Drug-Eluting Particles
Patent: 9,486,459 →
Application: 14/680,430 →
Publication: US 2015/0272965
Injector Apparatus
Application: 14/850,374 →
Publication: US 2016/0074213
Use of Sustained Release Dexamethasone in Post-Cataract Surgery Inflammation
Application: 14/893,381 →
Publication: US 2016/0120879
Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof
Patent: 9,849,085 →
Application: 14/919,962 →
Publication: US 2016/0038412
Sustained Release Formulations for the Treatment of Intraocular Pressure or Glaucoma
Patent: 9,636,347 →
Application: 15/018,461 →
Publication: US 2016/0151386
Injectable Sustained Release Intraocular Device
Application: 15/142,652 →
Publication: US 2016/0317438
Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents
Patent: 9,980,911 →
Application: 15/143,283 →
Publication: US 2017/0049703
Injectable Depot Formulations
Application: 15/147,198 →
Publication: US 2016/0324836
Networked Multi-Interface Host Debugger
Application: 15/147,208 →
Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents
Application: 15/167,066 →
Publication: US 2016/0346211
Bioerodible Silicon-Based Devices for Delivery of Therapeutic Agents
Patent: 9,808,421 →
Application: 15/299,050 →
Publication: US 2017/0035690
Porous silicon drug-eluting particles
Patent: 9,962,396 →
Application: 15/330,836 →
Publication: US 2017/0128464
Bioerodible Drug Delivery Devices
Application: 16/006,395 →
Publication: US 2018/0353431
Dose Guides for Injection Syringe
Application: 16/012,497 →
Publication: US 2018/0296765
Use of Sustained Release Dexamethasone in Post-Cataract Surgery Inflammation
Application: 16/018,931 →
Publication: US 2018/0303851
Sustained Release Dexamethasone Formulation
Application: 16/215,579 →
Publication: US 2019/0105330
Ocular Inserter
Patent: 851,755 →
Application: 29/543,267 →
HMGCoA reductase inhibitor-angiotensin converting enzyme inhibitor compounds
Application: 60/704,263 →
Control of induced elevated intraocular pressure
Application: 60/711,191 →
Injector apparatus and method of use
Application: 60/844,261 →
Bioerodible Drug Delivery Devices
Application: 62/518,739 →
Systems, Kits and Methods for Loading and Delivering a Small Volume Dose from a Syringe
Application: 62/628,446 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 9, 2004
From: CHEN, JIANBING; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015050/0890 →
Assignment of Assignor's Interest Aug 18, 2004
From: CHOU, KANG-JYE; GUO, HONG; ASHTON, PAUL; SHIMIZU, ROBERT W.
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015695/0061 →
Assignment of Assignor's Interest Nov 1, 2004
From: GUO, HONG; CHEN, JIANBING; SU, DONGLING; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 015325/0138 →
Assignment of Assignor's Interest Jun 14, 2005
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 016135/0697 →
License Agreement Oct 4, 2005
From: CONTROL DELIVERY SYSTEMS, INC.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 016851/0045 →
Assignment of Assignor's Interest Aug 23, 2007
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 019746/0493 →
Assignment of Assignor's Interest Oct 16, 2007
From: NAZZARO, MARTIN; GUO, HONG; LEBLANC, RON; YORK, JOSH
To: PSIVIDA INC.
Reel/Frame 019971/0644 →
Security Agreement Mar 26, 2008
From: BAUSCH & LOMB INCORPORATED; WP PRISM INC.; B&L CRL INC.; B&L CRL PARTNERS L.P.
To: CREDIT SUISSE
Reel/Frame 020733/0765 →
Merger Feb 19, 2009
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 022288/0245 →
Merger Jan 26, 2010
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 023849/0476 →
Merger Jan 26, 2010
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 023849/0635 →
Assignment of Assignor's Interest Jan 26, 2010
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 023849/0540 →
Assignment of Assignor's Interest Jan 26, 2010
From: GUO, HONG; ASHTON, PAUL
To: CONTROL DELIVERY SYSTEMS, INC.
Reel/Frame 023849/0399 →
Change of Name Feb 22, 2010
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 023968/0488 →
Assignment of Assignor's Interest Mar 10, 2010
From: ASHTON, PAUL
To: PSIVIDA US, INC.
Reel/Frame 024057/0285 →
Assignment of Assignor's Interest Jun 29, 2010
From: NAZZARO, MARTIN; GUO, HONG; LEBLANC, RON; YORK, JOSH
To: PSIVIDA US, INC.
Reel/Frame 024612/0058 →
Assignment of Assignor's Interest Apr 6, 2011
From: ASHTON, PAUL; GUO, HONG; CHEN, JIANBING; CANHAM, LEIGH
To: PSIVIDA US, INC.
Reel/Frame 026080/0901 →
Change of Name Jun 27, 2011
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 026509/0447 →
Change of Name Jan 30, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 027618/0261 →
Assignment of Assignor's Interest Feb 3, 2012
From: ASHTON, PAUL; CANHAM, LEIGH; BARNETT, CHRISTIAN
To: PSIVIDIA US, INC.
Reel/Frame 027650/0456 →
Merger Apr 6, 2012
From: CONTROL DELIVERY SYSTEMS, INC.
To: PSIVIDA INC.
Reel/Frame 028007/0782 →
Change of Name Apr 6, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 028008/0214 →
Change of Name Jun 27, 2012
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 028450/0310 →
Release of Security Interest Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
Change of Name Jul 30, 2013
From: PSIVIDA INC.
To: PSIVIDA US, INC.
Reel/Frame 030920/0061 →